Fulgent Genetics Inc (FLGT) Stock Price, Quote & News

Company Profile

Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer serv...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 626 350 0537

Fax: 626 454 1667

Website: www.fulgentgenetics.com

Address:

4399 Santa Anita Avenue, El Monte, United States

jf152 Jan. 9 at 9:17 PM

$FLGT The spread between the Bid and Ask on this stock are silly. This is why it is subject to low volume price manipulation. Also, before @sexydream celebrates a 4 penny decline today, a reminder: Fulgent is up 6% YTD.

1 · Reply

pilobious Jan. 8 at 9:41 PM

$FLGT Whining Verbotten!

0 · Reply

jf152 Jan. 8 at 9:38 PM

$FLGT What kind of person celebrates a 12 cent decline on a stock that's way up on the week? A bad person who has lies to peddle.

0 · Reply

Sexydream Jan. 8 at 7:44 PM

$FLGT @jf152 @Bigcoog2020 smh....we gonna go thru this again? Stock up 1 day and you guys resurface only to go silent again after it drops another 20%. Haven't you learned by now? Stock is at 27. Calm your panties. You guys act like it's gone to 100. Smh..... It's at 27. Geezus. What a bunch of bag holding losers we got here.

0 · Reply

jf152 Jan. 7 at 9:01 PM

$FLGT Up over 6% percentage since this terrible advice. @sexydream is just a bad person. He intentionally lies.

0 · Reply

jf152 Jan. 7 at 8:05 PM

$FLGT This was you warning! :)

0 · Reply

Bigcoog2020 Jan. 7 at 3:28 PM

$FLGT He is probably still recovering from squeeze in 2021😂

0 · Reply

jf152 Jan. 7 at 3:17 PM

$FLGT All @sexydream does is lie through his teeth. Not a single prediction is ever true.

0 · Reply

jf152 Jan. 7 at 3:08 AM

$FLGT After market activity

0 · Reply

Sexydream Jan. 5 at 8:34 AM

$FLGT Down 7 straight sessions. Will the streak continue to 8? Or will we have a dead cat bounce? One thing is clear. This is headed to $20! Don't be a clown like @jf152 and be stuck holding junk while everything else shoots up!

1 · Reply

Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx

Nov 11, 2025, 9:04 AM EST - 2 months ago

Fulgent Genetics, Inc. (FLGT) Presents at UBS Global Healthcare Conference 2025 Transcript

Nov 7, 2025, 4:05 PM EST - 2 months ago

Fulgent to Participate in Upcoming Conferences

Nov 7, 2025, 2:56 PM EST - 2 months ago

Fulgent Genetics, Inc. (FLGT) Q3 2025 Earnings Call Transcript

Nov 7, 2025, 7:05 AM EST - 2 months ago

Fulgent Reports Third Quarter 2025 Financial Results

Oct 20, 2025, 6:00 AM EDT - 2 months ago

Fulgent Shares Preliminary Data from Poster Presentation at ESMO 2025 Conference

Oct 16, 2025, 7:00 AM EDT - 3 months ago

Fulgent to Announce Third Quarter 2025 Financial Results on Friday, November 7, 2025

Sep 8, 2025, 1:58 PM EDT - 4 months ago

Fulgent Genetics: Core Growth Re-Acceleration And Gross Margin Expansion Are On Track (Reiterate Buy)

Aug 1, 2025, 12:28 PM EDT - 5 months ago

Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call Transcript

Aug 1, 2025, 7:00 AM EDT - 5 months ago

Fulgent Reports Second Quarter 2025 Financial Results

Jul 17, 2025, 7:00 AM EDT - 6 months ago

Fulgent Genetics Receives EU CE Mark for FulgentExome & FulgentPLM

Jul 10, 2025, 4:05 PM EDT - 6 months ago

Fulgent to Announce Second Quarter 2025 Financial Results on Friday, August 1, 2025

Jun 10, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fulgent Genetics, Inc. (FLGT) And Encourages Shareholders to Reach Out

Jun 9, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Shareholders to Learn More About the Investigation

Jun 8, 2025, 10:00 AM EDT - 7 months ago

Fulgent Genetics, Inc. (FLGT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Jun 6, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Fulgent Genetics, Inc. (FLGT) Shareholders to Inquire about Securities Investigation

Jun 5, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fulgent Genetics, Inc. (FLGT) And Encourages Investors to Connect

Jun 4, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Fulgent Genetics, Inc. (FLGT) Stockholders to Inquire about Securities Investigation

Jun 3, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Investors to Learn More About the Investigation

Jun 2, 2025, 10:00 AM EDT - 7 months ago

Fulgent Genetics, Inc. (FLGT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

May 30, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fulgent Genetics, Inc. (FLGT) And Encourages Stockholders to Connect

May 29, 2025, 10:00 AM EDT - 8 months ago

Fulgent Genetics, Inc. (FLGT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

May 28, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Stockholders to Learn More About the Investigation

May 27, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Fulgent Genetics, Inc. (FLGT) Investors to Inquire about Securities Investigation

May 24, 2025, 9:19 PM EDT - 8 months ago

FLGT Investors Have Opportunity to Join Fulgent Genetics, Inc. Fraud Investigation with the Schall Law Firm

May 19, 2025, 8:11 AM EDT - 8 months ago

Wolf Haldenstein Adler Freeman & Herz LLP is investigating Fulgent Genetics, Inc

May 2, 2025, 12:27 PM EDT - 9 months ago

Fulgent Genetics, Inc. (FLGT) Q1 2025 Earnings Call Transcript

May 2, 2025, 7:00 AM EDT - 9 months ago

Fulgent Reports First Quarter 2025 Financial Results

Apr 10, 2025, 4:05 PM EDT - 9 months ago

Fulgent to Announce First Quarter 2025 Financial Results on Friday, May 2, 2025

Apr 4, 2025, 2:30 PM EDT - 10 months ago

Stock Picks From Seeking Alpha's March 2025 New Analysts

AI ARGX CCL CEPU CF CROX CUK

Mar 20, 2025, 5:46 AM EDT - 10 months ago

Fulgent Genetics: Undervalued, CFO Buying, And Promising Drug Candidates Make It A Buy

Feb 28, 2025, 11:57 AM EST - 11 months ago

Fulgent Genetics, Inc. (FLGT) Q4 2024 Earnings Conference Call Transcript

Feb 28, 2025, 7:00 AM EST - 11 months ago

Fulgent Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 6, 2025, 4:05 PM EST - 1 year ago

Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025

Feb 4, 2025, 4:00 PM EST - 1 year ago

Foundation Medicine to Launch Hereditary Germline Tests, FoundationOne®Germline and FoundationOne®Germline More, in the United States Through a Partnership with Fulgent Genetics

Dec 24, 2024, 1:25 AM EST - 1 year ago

Fulgent Genetics: High Insider Ownership Supports Asymmetric Upside

Nov 11, 2024, 2:07 AM EST - 1 year ago

Fulgent Genetics, Inc. (FLGT) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 7:00 AM EST - 1 year ago

Fulgent Reports Third Quarter 2024 Financial Results

Oct 31, 2024, 8:00 AM EDT - 1 year ago

Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1

Oct 17, 2024, 4:05 PM EDT - 1 year ago

Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024

Sep 25, 2024, 11:32 AM EDT - 1 year ago

Fulgent Genetics: An NCAV Pick With Profit And Growth Potential

Sep 9, 2024, 12:05 PM EDT - 1 year ago

Fulgent Genetics: Core Growth Re-Acceleration Will Be The Critical Catalyst

Aug 2, 2024, 10:24 AM EDT - 1 year ago

Fulgent Genetics, Inc. (FLGT) Q2 2024 Earnings Call Transcript

Aug 2, 2024, 7:00 AM EDT - 1 year ago

Fulgent Reports Second Quarter 2024 Financial Results

Jul 11, 2024, 4:05 PM EDT - 1 year ago

Fulgent to Announce Second Quarter 2024 Financial Results on Friday, August 2, 2024

Jun 10, 2024, 1:00 AM EDT - 1 year ago

Press release Biocartis NV: Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing

NEO

jf152 Jan. 9 at 9:17 PM

1 · Reply

pilobious Jan. 8 at 9:41 PM

$FLGT Whining Verbotten!

0 · Reply

jf152 Jan. 8 at 9:38 PM

$FLGT What kind of person celebrates a 12 cent decline on a stock that's way up on the week? A bad person who has lies to peddle.

0 · Reply

Sexydream Jan. 8 at 7:44 PM

0 · Reply

jf152 Jan. 7 at 9:01 PM

$FLGT Up over 6% percentage since this terrible advice. @sexydream is just a bad person. He intentionally lies.

0 · Reply

jf152 Jan. 7 at 8:05 PM

$FLGT This was you warning! :)

0 · Reply

Bigcoog2020 Jan. 7 at 3:28 PM

$FLGT He is probably still recovering from squeeze in 2021😂

0 · Reply

jf152 Jan. 7 at 3:17 PM

$FLGT All @sexydream does is lie through his teeth. Not a single prediction is ever true.

0 · Reply

jf152 Jan. 7 at 3:08 AM

$FLGT After market activity

0 · Reply

Sexydream Jan. 5 at 8:34 AM

1 · Reply

pilobious Jan. 2 at 8:06 PM

$FLGT man I love this stock. Just bought my first call for earnings. Feb 20 strike. $6.30. It’s the only one sold. Eventually I plan to add 9-10 more. Got plenty of time. Earnings will be solid again.

0 · Reply

Endergast07 Jan. 2 at 4:29 PM

$FLGT I hope it reaches 22.50 before earnings, then I load again. If they gift me with below 20 prices like @Sexydream predicts, then I will be extra happy

1 · Reply

Sexydream Jan. 2 at 4:04 PM

$FLGT @jf152 Happy new year. Still don't wanna listen to daddy? I'm just trying to save my son from losing too much $$ holding turds. When stock was at 31, I called 25. 25 is here. Daddy is calling 20. Give it 8 weeks. LOSER

0 · Reply

Sexydream Dec. 31 at 4:37 AM

$FLGT Going below 20 in the next 6-8 weeks. I am up almost 100% on my puts in 2 weeks lolol

2 · Reply

Sexydream Dec. 30 at 4:03 PM

$FLGT @Bigcoog2020 @jf152 @Fuchebol DADDY IS NEVER WRONG. You can still sell and recover whatever little pennies you have left from holding this bag. Hahahahah IDIOTS. We will see $20 very soon. Market at all time highs and you're suck holding this junk at 25. Wonder what that feels like!

1 · Reply

Sexydream Dec. 26 at 8:21 PM

$FLGT @jf152 @Fuchebol Merry Christmas losers. Daddy is back from his short but sweet vacation. Miss me? As I said would happen, stock is down everyday. IDIOTS. LOLOLLL. Ready for 25? And then $20? No? Too bad. It's coming. 🤣

2 · Reply

MichelangeloM Dec. 25 at 11:49 AM

$FLGT The next leg of valuation movement will likely hinge on how management navigates competing priorities. Operating leverage needs to emerge without sacrificing balance‑sheet resilience. Without proof, upside scenarios remain hypothetical and heavily discounted. Catalysts help, but operating proof ultimately carries the most weight.

1 · Reply

jf152 Dec. 24 at 4:47 PM

$FLGT

0 · Reply

ZacksResearch Dec. 23 at 6:15 PM

$FLGT making a strategic move — this is about scale, not noise. 🔍📈 Fulgent is set to acquire Bako Diagnostics assets and StrataDx for $55.5M, expanding into anatomic pathology and dermatopathology to broaden its pathology platform and scale lab services. That’s a clear push into higher-value capabilities. See how this acquisition reshapes the growth story 👉 https://www.zacks.com/stock/news/2808173/flgt-to-acquire-bako-stratadx-assets-to-expand-pathology-platform?cid=sm-stocktwits-2-2808173-teaser-26085&ADID=SYND_STOCKTWITS_TWEET_2_2808173_TEASER_26085

0 · Reply

ZacksResearch Dec. 23 at 5:15 PM

$FLGT eyes growth with $55.5M acquisition of Bako Diagnostics & StrataDx! 🚀 🧬 Expanding into pathology and dermatopathology services 🤖 Leveraging AI to boost efficiency and test quality 📈 Over the past six months, shares have climbed 43%, outpacing industry and S&P 500 Discover the full strategy behind FLGT's moves here 👉 https://www.zacks.com/stock/news/2808173/flgt-to-acquire-bako-stratadx-assets-to-expand-pathology-platform?cid=sm-stocktwits-2-2808173-body-26065&ADID=SYND_STOCKTWITS_TWEET_2_2808173_BODY_26065

0 · Reply

v92 Dec. 23 at 12:35 AM

$FLGT

0 · Reply

Sexydream Dec. 22 at 5:21 PM

$FLGT @jf152 @Fuchebol good morning from Italy losers. Russell 2000 flying high again while junk stock flgt down. Hahaha I love it when you get huffy and puffy over an online post I make. Good to see you love me that much. I am your daddy. Thanks for the love and the money you give me thru my puts. While other stocks double and triple, you're stuck holding a bag. Hahahahahah IDIOTS

1 · Reply

Market Cap	865.85M
Revenue (ttm)	283.47M
Net Income (ttm)	-42.71M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-15.07%
Debt to Equity Ratio	0.00

Volume	228,464
Avg Vol	288,720
Day's Range	N/A - N/A
Shares Out	30.91M
Stochastic %K	87%
Beta	0.63
Analysts	Sell
Price Target	$33.67